Skip to content
OpenCapital
Get started

Spire Global SPIR Concentration Risk %

Concentration Risk % at other companies

Gyre Therapeutics, Inc. logo
Gyre Therapeutics, Inc.GYRE
93.1%-5.3pp
Heartland Express logo
Heartland ExpressHTLD
32%+6.0pp
Enovix Corporation logo
Enovix CorporationENVX
83%+36.0pp
Weis Markets logo
Weis MarketsWMK
100%0.0pp
Innoviva, Inc. logo
Innoviva, Inc.INVA
36%+7.0pp
Strattec Security logo
Strattec SecuritySTRT
0.5%0.0pp

Segments

By geography

See full
EMEA73%+115%
Americas65%+14.0%
Other Region Of EMEA6%—
Asia Pacific3%-66.7%
Other Region Of Asia Pacific3%—
Other Region Of Americas0%—

Other financials

Income statement

See full
Revenue$15.8M-33.7%
Gross profit$6.3M-27.6%
Operating income-$24.6M+13.1%
Net income-$25.8M-9.9%
EPS (diluted)-$0.78+11.4%

Balance sheet

See full
Cash & equivalents$16.0M-55.3%
Total debt$11.8M-89.6%
Total equity$91.2M+2,355%
Total assets$182.9M-12.4%

Cash flow

See full
Operating cash flow-$26.2M-211%
CapEx$8.0M-10.4%
Free cash flow-$34.2M-97.2%

Valuation

See full
Market cap$619M+100%
Enterprise value$614.72M+59.3%
P/E12.2×—
P/S9.8×+6.6×

Profitability

See full
Gross margin42.1%+2.6pp
Operating margin-145.3%+322pp
Net margin35.7%+23.4pp
FCF margin-172.3%—

Returns & leverage

See full
Return on equity33.7%+18.3pp
Debt / equity0.1×-30.3×
Current ratio0.9×+0.3×